Procainamide 1 gram/10 ML vial 10ML
Ended Awarded Last action
- Contract number
- SPE2DR26FD6YW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,116
Award facts
- Contract value 100% obligated
- $9,116.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Procainamide 1 gram/10 milliliter vials totaling $9,116.21 with an ultimate completion date of January 30, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award was fulfilled by AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, where the product will be performed. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s comprehensive Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
Procainamide is an antiarrhythmic medication used to treat cardiac arrhythmias, and this order represents a routine pharmaceutical replenishment for military medical treatment facilities and related defense health operations. The delivery order underscores DLA's reliance on established prime vendor relationships to efficiently procure essential medications and medical commodities. AmerisourceBergen's extensive federal contracting history with multiple therapeutic domains, combined with its significant IDC with DLA, positions the company as a critical supplier within the Department of Defense's pharmaceutical supply chain serving military healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DR26FD6YW?
SPE2DR26FD6YW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FD6YW worth?
The government has obligated $9,116 on SPE2DR26FD6YW.
Is contract SPE2DR26FD6YW an order under another contract?
Yes. SPE2DR26FD6YW is a delivery order under SPE2DR25D2209, an indefinite delivery contract.
Was contract SPE2DR26FD6YW competed?
The extent of competition for SPE2DR26FD6YW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award